Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 4—April 2022
Research Letter

Early Circulation of SARS-CoV-2, Congo, 2020

Novy Charel Bobouaka Bonguili1, Matthieu Fritz1, Leadisaelle Hosanna Lenguiya, Pembe Issamou Mayengue, Félix Koukouikila-Koussounda, Louis Régis Dossou-Yovo, Cynthia Nkoua Badzi, Eric M. Leroy, and Fabien R. NiamaComments to Author 
Author affiliations: Laboratoire National de Santé Publique, Brazzaville, Republic of Congo (N.C. Bobouaka Bonguili, L.H. Lenguiya, P. Issamou Mayengue, F. Koukouikila-Koussounda, L.R. Dossou-Yovo, C. Nkoua Badzi, F.R. Niama); Université Marien Ngouabi, Brazzaville (N.C. Bobouaka Bonguili, L.H. Lenguiya, P. Issamou Mayengue, F. Koukouikila-Koussounda, L.R. Dossou-Yovo, F.R. Niama); Université de Montpellier, Montpellier, France (M. Fritz, E.M. Leroy); Institut de Recherche pour le Développement, Unité Mixte de Recherche MIVEGEC, Montpellier (M. Fritz, E.M. Leroy)

Main Article

Table

Seropositivity of SARS-CoV-2 IgG among persons with HIV, Congo, July 2019–February 2020*

Sample No. tested/no positive (% positive) p value
Sex
F 655/22 (3.3) 0.38
M 241/5 (2.1)
Unknown
 41/1 (2.4)
 NA
Location 0.0052 for Brazzaville 2020 vs. 2019; 0.8 for Brazzaville 2020 vs. Pointe-Noire 2020
Brazzaville 2019 453/4 (0.8)
Brazzaville 2020 110/6 (5.4)
Pointe-Noire 2020
 374/18 (4.8)
Date
2019 September–December 453/4 (0.9) 0.0002
2020 January–February
 484/24 (4.9)
Total 937/28 (3.0) NA

*NA, not applicable; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Main Article

1These first authors contributed equally to this article.

Page created: February 07, 2022
Page updated: March 19, 2022
Page reviewed: March 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external